Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Mar 15, 2007 (Vol. 27, No. 6)

Biosnail

URL:www.biosnail.com
  • Lots of interview/cover letter material
  • Poorly organized, ridiculous HTML coding
This career-related site wins points for its aims though its delivery leaves a lot to be desired. Biosnail is focused not on listing jobs but rather on preparation for interviews and making first impressions. The job listing section of the site offers only links to other sites with jobs. Indeed, all the offerings of the site seem to be links to other sites with everything from resume tips to sample resumes to cover letters to resume software. In the Safari browser, the site had a bizarre behavior. Each link, when clicked on, generated a new window behind the main one. Firefox, however, didn’t give the same result. If you’re willing to wade through a lot of links and advertisements, you’re likely to find some useful career-related material, but I must seriously question if it is worth the effort.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »